AMST Amesite

Amesite’s Dr. Ann Marie Sastry Featured as Guest Speaker at the Newsmakers: Lesher Speaker Series

Amesite’s Dr. Ann Marie Sastry Featured as Guest Speaker at the Newsmakers: Lesher Speaker Series

DETROIT, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today its Founder and CEO, Dr. Ann Marie Sastry, was featured as a guest speaker at the  on October 24, 2024, following Former U.S. Representative Liz Cheney, Former World #1 Tennis Player and Founder of Chris Evert Charities, Chris Evert, Host of CNN's Smerconish and Best-Selling Author, Michael Smerconish and other eminent thinkers and experts.

Dr. Sastry talked about the impact of AI, and said that “AI allows you to reimagine yourself, and your capabilities.” Commenting on the impact of AI in healthcare, Dr. Sastry said, “Technology exists that passes the U.S. Medical License Exam. Why wouldn’t I want my healthcare provider to use AI? In fact, it’s super crazy not to…we looked at this market and said, there are 5.2 million RNs and about 3.9 million caregivers, so we [at Amesite] said, ‘let’s go help them’... My firm belief is that collectively the impact will be profound…it will be considered unethical not to use AI [in healthcare].”

Key topics covered by Dr. Sastry included:

  • AI as a tool for enhancing human capabilities, driven by human creativity.
  • Generative AI's impact on jobs, automating tasks and shifting roles toward AI management.
  • Need for rapid AI adoption in business to stay competitive.
  • Ethical concerns around AI’s lack of empathy, emphasizing responsible use and regulation.
  • AI’s role in transforming healthcare, offering personalized, scalable support that improves patient care.

A video accompanying this announcement is available at 

About Amesite Inc.

Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. , the company’s mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.

Forward Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:

MJ Clyburn

TraDigital IR

Sources:

  1. /2021/05/national-association-of-clinical-nurse-specialists-releases-census-results/#:~:text=The%20NACNS%202020%20census%20was,practice%20and%20education%20of%20CNSs.
  2. /about/all-about-nps/np-fact-sheet
  3. /news-data/fact-sheets/nursing-workforce-fact-sheet
  4. /cpns-numbers
  5. /oes/2023/may/oes291123.htm
  6. /oes/2023/may/oes291122.htm
  7. /oes/2023/may/oes292061.htm
  8. /oes/2023/may/oes311131.htm#(1)
  9. /home-care-nurse-jobs/demographics/
  10. /profile/soc/home-health-aides?redirect=true
  11. /resources/caregivers-in-america
  12. /support-specialist-jobs/demographics/


EN
31/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amesite

 PRESS RELEASE

Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive...

Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable Market New Tier Adds EMR Integration, Team Reporting (IDT) and Custom Form Support — Enabling Scalable Deployment Across Entire Patient Census DETROIT, July 14, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced the launch of the new NurseMagic™ Enterprise Tier, built to meet the most urgent needs of mid- and large-scale post-acute healthcare providers. Develo...

 PRESS RELEASE

Amesite’s HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages...

Amesite’s HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses NurseMagic™ V3.0 uniquely addresses the needs of approximately 20% of U.S. nurses in the U.S. with AI-powered charting in their native language DETROIT, June 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced that its flagship app, NurseMagic™, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 ...

 PRESS RELEASE

Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing

Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing Company Reports Accelerated Growth for both B2C and B2B, with Outstanding Customer Reviews into Q4 DETROIT, May 16, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced its flagship app NurseMagicTM generated 2.4x revenue from Q2/2025 to Q3/2025, even as the company continued to cut operating expenses. Sarah Berman, Principal Financial and Accounting Officer, said, “Our revenues are presently evenly distributed between B2B and B2C sales. Following...

 PRESS RELEASE

Amesite Announces Successful Launch of New, Higher-Priced Tier of Serv...

Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand NurseMagic Teams Plus+ Meets Businesses’ Increasingly Intensive Use of App, and Meets Demand for Team Analytics DETROIT, May 06, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced the successful launch of a higher-priced enterprise tier of service of its flagship app, NurseMagicTM. Amesite reports that businesses demanded more capacity after incorporating NurseMagicTM fully into their workflows – and have reported ...

 PRESS RELEASE

Amesite Announces NurseMagic™ Meets HIPAA Requirements for Individuals...

Amesite Announces NurseMagic™ Meets HIPAA Requirements for Individuals Users, in Addition to Enterprises NurseMagic™ Now Supports Healthcare Workers in Any Care Setting, Allowing Every Provider to Store Confidential Patient Information DETROIT, April 22, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced NurseMagic™ now meets HIPAA requirements for all users. This extension ensures that all usage—individual or enterprise—meets regulatory standards for handlin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch